Harmony Biosciences Holdings, Inc. is a neuroscience company focused on rare neurological diseases. Its lead commercial product, WAKIX (pitolisant), is an FDA-approved, first-in-class H3 receptor antagonist/inverse agonist for narcolepsy in adults and pediatric patients. The company also has pipeline assets including next-generation pitolisant formulations, EPX-100 and EPX-200 for rare epilepsy, an orexin 2 receptor agonist (BP1.15205), and two discovery-stage cell replacement therapy candidates for narcolepsy and epilepsy.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001104659-26-018859 | EDGAR | 91K words |
| 2025-02-25 | 2024-12-31 | 0001558370-25-001441 | EDGAR | 87K words |
| 2024-02-22 | 2023-12-31 | 0001558370-24-001466 | EDGAR | 92K words |
| 2023-02-21 | 2022-12-31 | 0001558370-23-001574 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002257 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015274 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-04 | 2026-06-30 | 0001104659-26-090090 | EDGAR | 27K words |
| 2025-11-04 | 2025-09-30 | 0001104659-25-105962 | EDGAR | 27K words |
| 2025-08-05 | 2025-06-30 | 0001558370-25-010185 | EDGAR | 26K words |
| 2025-05-06 | 2025-03-31 | 0001558370-25-006394 | EDGAR | 24K words |
| 2024-10-29 | 2024-09-30 | 0001558370-24-013803 | EDGAR | 26K words |
| 2024-08-06 | 2024-06-30 | 0001558370-24-010956 | EDGAR | 24K words |
| 2024-04-30 | 2024-03-31 | 0001558370-24-006203 | EDGAR | 22K words |
| 2023-10-31 | 2023-09-30 | 0001558370-23-017060 | EDGAR | 23K words |
| 2023-08-01 | 2023-06-30 | 0001558370-23-012637 | EDGAR | 20K words |
| 2023-05-02 | 2023-03-31 | 0001558370-23-007571 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001558370-22-015726 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001558370-22-011556 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001104659-26-090086 | EDGAR | 4K words |
| 2026-07-16 | 0001104659-26-084095 | EDGAR | 1K words |
| 2026-04-02 | 0001104659-26-038888 | EDGAR | 9K words |
| 2026-02-24 | 0001104659-26-018858 | EDGAR | 6K words |
| 2026-01-12 | 0001104659-26-002731 | EDGAR | 4K words |
| 2025-11-04 | 0001104659-25-105942 | EDGAR | 6K words |
| 2025-10-23 | 0001104659-25-101688 | EDGAR | 2K words |
| 2025-09-24 | 0001104659-25-092776 | EDGAR | 1K words |
| 2025-08-05 | 0001558370-25-010182 | EDGAR | 6K words |
| 2025-06-11 | 0001558370-25-008525 | EDGAR | 1K words |
109 total filings indexed. 81 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001802665 |
| Ticker | HRMY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.harmonybiosciences.com |
| Listed | 2020-08-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HRMY (~200 tokens, structured JSON with cryptographic provenance)